An interventional study of Motivational Interview (MI) & Adherence Follow-Up and Adherence Follow-Up in Sleep Apnea, Obstructive, sponsored by Air Liquide Healthcare Spain. Status unknown at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-12-02.
Sponsored by Air Liquide Healthcare Spain (part of Air Liquide) · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Sleep Apnea, Obstructive with a site in Portugal — 2 open to participants now, 3 under way, none of them phase 3. Sleep Apnea, Obstructive · Portugal.
Among the 13 studies in Sleep Apnea, Obstructive with a site in Portugal, this one is one of 2 that started in 2020, is one of 5 with no phase, and was the 8th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →2 of the 13 studies in Sleep Apnea, Obstructive with a site in Portugal are open now. Recruiting first, the newest first:
Aveiro University · Sites in Portugal
Ages 18–80
Wissenschaftliches Institut Bethanien e.V · Sites in Portugal, Belgium, France and 8 more countries
Ages 40+
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2020.
This study's planned enrollment of 200 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 113 across the 5 interventional studies, 162 across the 8 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 13 have an industry lead sponsor. The 10 most frequent:
This study is registered under Air Liquide Healthcare Spain, one of the names counted as Air Liquide. Under that name alone:
Air Liquide Healthcare Spain is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Air Liquide has 4 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Sleep Apnea, Obstructive with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Continuous positive airway pressure (CPAP) is the first-line treatment for sleep apnoea/hypopnoea syndrome (OSA). The aim of this study is to know the results in adherence to CPAP and health related outcomes in patients with OSA through a comprehensive and multidisciplinary program based on stratification and individualized care plans, including the motivational interview.
Methods: A multicenter randomized controlled trial (RCT) is designed. The control group will follow the usual treatment, while the intervention group (PIMA) will follow the treatment according to the stratification label based on a comprehensive assessment. This label determines a personalized treatment plan for each patient, which includes different channels (home, telephone, care center) and the use of the motivational interview in each of the interventions with the patient. The main outcome was adherence. Secondary outcomes were quality of life, emotional state, activities, social relationships, perceived competence and motivation.
The subjects enrolled in the study are required to have a diagnosis of OSA confirmed by sleep studies with polygraphy (PS) and / or polysomnography(PSG). Prior to enrolment in the study, all patients are informed in detail about the study and signed the consent form to participate. A randomisation process will follow using a random number generator in Statistical Package for the Social Sciences (SPSS) to systematically assign patients to one group or another, with allocation concealment. Responsible for randomization are prescribers.
The control group intervention. The patients will follow the standard of care, which consists of starting therapy in the home, where the nurse perform training in the use of CPAP equipment, mask adjustment, and safety and maintenance instructions. For follow-up, the patient is always visited at home or telephone, with a frequency established by the Portuguese Society of Sleep(Day 7, Day 21 and Day 180). The follow-up procedure consists of reviewing the CPAP hour meter and resolving any incidents that may have arisen, with the necessary corrective actions (change of mask, positive reinforcement, explanation of specific aspects).
The intervention group 'PIMA' (Personalized Adherence Improvement Plan, based on the Spanish acronym), starts the treatment with the educational and training program called MEntA (Motivational Interview for Adherence). MEntA intervention consists of one session lasting approximately 60 minutes, which is divided into two blocks: educational activity and training activity. In the first block, nurse explains the concepts of sleep apnoea and the symptoms, while a patient shows the CPAP treatment and how to optimize this to the fullest. This block is reinforced with documentation in hard copy and digital format. The second block on training activity was based on working with the treatment, equipment, safety, hygiene and advice. MEntA uses the MI to the treatment of OSA with CPAP. In fact, the nurse uses MI not only at the beginning of therapy, but also in every contact that the patient has with the patient throughout the treatment (subsequent follow-up visits, phone calls, etc). For the PIMA group, the nurse was specifically trained to give this intervention to patients, including a training session with a clinical psychologist.
After the educational and training program, the nurse performs the stratification process to know a series of patient characteristics that will allow identifying the best care plan to obtain the best results in adherence and quality of life. The stratification labels that determine the personalized intervention plan are obtained from two types of variables: personal and modulation variables.With the psychological and clinical variables, in this first visit, "predictive" information is obtained on how the patient's adherence will be: high adherence, moderate adherence or low adherence. Taking this information into account, the care plan will start considering how the patient is and their situation with respect to adherence. Low or moderate adherence relative face plans are more intensive than high adherence relative care plans. In follow-up visits (whose frequency depends on the level of adherence), psychological and clinical variables are reviewed and the patient's adherence is added. Depending on their evolution, the care plan is adapted. For patients with low adherence, telemonitoring is used with hours of compliance, the Apnea-hypoanea index(AHI) and air leak.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1. MEntA: Educational \& Training Program 2. Stratification: Identification of Personal Variables (Age, Level of study, Work status, preference of care attention, digital behaviour) 3. Adherence evaluation: Evaluation of Perceived Competence, Quality of Life, Mood, Activities, Social relations and Social Support 4. Identification of Care plan and Schedule next visits 5. Follow-up D21-D90-D120-D180 depending of the care plan, through the channel that belong for each care plan
Behavioral: Motivational Interview (MI) & Adherence Follow-Up
1. Training program 2. Schedule next visits 3. Follow-up D21-D90-D120-D180 using the same process: visit at home or phone.
Device: Adherence Follow-Up
With MI, the key goal is to empower the patient to commit to follow CPAP therapy, while providing empathic support, in a positive atmosphere, and without prejudice. The nurse does not directly advocate for behavior change (i.e. use CPAP as prescribed), but asks key questions to help the patient explore their feelings about the change, weighs the pros and cons of such change, and allows the patient to realize the discrepancy between the current risk (that is, not using CPAP as directed) and the benefits with good adherence.
The nurse takes the compliance of the CPAP device, and ask to the patient if he had some problems.
Change in adherence in the first 6 months of treatment
Number of hours using CPAP per night
Time frame: Day 21, Day 90, Day 120, Day 180
Change in somnolence in the first 6 months of treatment
Residual sleepiness after use of CPAP. Epworth Test
Time frame: Day 21, Day 90, Day 120, Day 180
Change in perceived competence in the first 6 months of treatment
Self-Efficacy in the CPAP treatment. Perceived Competence Evaluation Questionnaire
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Apnea-hypoanea index in the first 6 months of treatment
Number of apneas-hypoapneas per night
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Air Leaks in the first 6 months of treatment
Fly away through the suitcase adaptation of the mask. Measured in liters / per minute
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Quality of Life in the first 6 months of treatment
Well-Being of the patient related to sleep apnea. Analogical Well-Being in Sleep Apnea Scale
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Mood in the first 6 months of treatment
Emotional status related to sleep apnea. Ad hoc question
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Activities in the first 6 months of treatment
Improving general activity after use CPAP. Ad hoc question
Time frame: Day 21, Day 90, Day 120, Day 180
Change in Social Relationships in the first 6 months of treatment
Improving general social relations after use CPAP. Ad hoc question
Time frame: Day 21, Day 90, Day 120, Day 180
Plan to share: Yes — Publication of results in two phases: National Congress in Portugal Publication in Research Journal
Supporting information: Study protocol, Statistical analysis plan, Clinical study report
Time frame: Q3 - 2021
No publications or documents are linked to this record.
Started Oct 2020 (actual). Primary completion is estimated for Jan 2021, 3 months after the start.
Of 118 industry-sponsored interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 3 months is below that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Air Liquide Healthcare Spain →